Prior to the SARS-CoV-2 pandemic, antibiotic resistance was listed as the major global
health care priority. Some analyses, including the O'Neill report, have predicted that deaths …

Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …

Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory
distress syndrome (ARDS) has emerged as an important disease that predisposes patients …

Pneumonia caused by severe acute respiratory syndrome coronavirus 2 emerged in China
at the end of 2019. Because of the severe immunomodulation and lymphocyte depletion …

Bacterial or virus co-infections with severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) have been reported in many studies, however, the knowledge on Aspergillus co …

Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis
(CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

Since the beginning of 2020, the ongoing coronavirus disease (COVID-19) pandemic has
resulted in the deaths of more than 250,000 patients in the European Union/European …

Aspergillosis complicating severe influenza infection has been increasingly detected
worldwide. Recently, coronavirus disease–associated pulmonary aspergillosis (CAPA) has …

Background The incidence of secondary pulmonary infections is not well described in
hospitalized COVID-19 patients. Understanding the incidence of secondary pulmonary …

Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …